Article
Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach.
Stroke - 1 Aug 2006
Zee Robert Y L, Cheng Suzanne, Hegener Hillary H, Erlich Henry A, Ridker Paul M
Abstract excerpt
BACKGROUND AND PURPOSE: Recent findings have implicated specific gene polymorphisms of arachidonate 5-lipoxygenase-activating protein (ALOX5AP), and 2 at-risk haplotypes (HapA, HapB) in myocardial infarction and stroke. To date, no prospective data are available. METHODS: We evaluated 10 specific Icelandic ALOX5AP gene variants among 600 male participants with incident atherothrombotic events (myocardial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
